These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Immunohistochemical Expression of CD31 (PECAM-1) in Nonendothelial Tumors of Dogs. Ramos-Vara JA; Miller MA; Dusold DM Vet Pathol; 2018 May; 55(3):402-408. PubMed ID: 29343200 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma. Kanavaros P; Stefanaki K; Vlachonikolis J; Papalazarou D; Rontogianni D; Arvanitis D; Antonakopoulos G; Gorgoulis V; Bai M; Agnantis NJ Anticancer Res; 2000; 20(6B):4619-25. PubMed ID: 11205312 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Wader KF; Fagerli UM; Børset M; Lydersen S; Hov H; Sundan A; Bofin A; Waage A Histopathology; 2012 Feb; 60(3):443-51. PubMed ID: 22276607 [TBL] [Abstract][Full Text] [Related]
14. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma. Sheth N; Yeung J; Chang H Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468 [TBL] [Abstract][Full Text] [Related]
15. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation. Sanal SM; Yaylaci M; Mangold KA; Pantazis CG Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506 [TBL] [Abstract][Full Text] [Related]
16. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis? Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571 [TBL] [Abstract][Full Text] [Related]
17. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease. Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N Br J Haematol; 2013 May; 161(3):373-82. PubMed ID: 23431957 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance. Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871 [TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]